218 related articles for article (PubMed ID: 18669882)
21. Dietary cholesterol plays a role in CD36-mediated atherogenesis in LDLR-knockout mice.
Kennedy DJ; Kuchibhotla SD; Guy E; Park YM; Nimako G; Vanegas D; Morton RE; Febbraio M
Arterioscler Thromb Vasc Biol; 2009 Oct; 29(10):1481-7. PubMed ID: 19608973
[TBL] [Abstract][Full Text] [Related]
22. Activation of Adiponectin Receptor Regulates Proprotein Convertase Subtilisin/Kexin Type 9 Expression and Inhibits Lesions in ApoE-Deficient Mice.
Sun L; Yang X; Li Q; Zeng P; Liu Y; Liu L; Chen Y; Yu M; Ma C; Li X; Li Y; Zhang R; Zhu Y; Miao QR; Han J; Duan Y
Arterioscler Thromb Vasc Biol; 2017 Jul; 37(7):1290-1300. PubMed ID: 28546220
[TBL] [Abstract][Full Text] [Related]
23. Human PCSK9 promotes hepatic lipogenesis and atherosclerosis development via apoE- and LDLR-mediated mechanisms.
Tavori H; Giunzioni I; Predazzi IM; Plubell D; Shivinsky A; Miles J; Devay RM; Liang H; Rashid S; Linton MF; Fazio S
Cardiovasc Res; 2016 May; 110(2):268-78. PubMed ID: 26980204
[TBL] [Abstract][Full Text] [Related]
24. Low carbohydrate, high protein diet promotes atherosclerosis in apolipoprotein E/low-density lipoprotein receptor double knockout mice (apoE/LDLR(-/-)).
Kostogrys RB; Franczyk-Żarów M; Maślak E; Gajda M; Mateuszuk L; Jackson CL; Chłopicki S
Atherosclerosis; 2012 Aug; 223(2):327-31. PubMed ID: 22771189
[TBL] [Abstract][Full Text] [Related]
25. Effects of probucol on atherosclerosis of apoE-deficient or LDL receptor-deficient mice.
Yoshikawa T; Shimano H; Chen Z; Ishibashi S; Yamada N
Horm Metab Res; 2001 Aug; 33(8):472-9. PubMed ID: 11544561
[TBL] [Abstract][Full Text] [Related]
26. Ticlopidine attenuates progression of atherosclerosis in apolipoprotein E and low density lipoprotein receptor double knockout mice.
Jawien J; Csanyi G; Gajda M; Mateuszuk L; Lomnicka M; Korbut R; Chlopicki S
Eur J Pharmacol; 2007 Feb; 556(1-3):129-35. PubMed ID: 17174298
[TBL] [Abstract][Full Text] [Related]
27. Increase in secretory sphingomyelinase activity and specific ceramides in the aorta of apolipoprotein E knockout mice during aging.
Kobayashi K; Nagata E; Sasaki K; Harada-Shiba M; Kojo S; Kikuzaki H
Biol Pharm Bull; 2013; 36(7):1192-6. PubMed ID: 23811568
[TBL] [Abstract][Full Text] [Related]
28. ApoE-dependent modulation of HDL and atherosclerosis by G2A in LDL receptor-deficient mice independent of bone marrow-derived cells.
Parks BW; Srivastava R; Yu S; Kabarowski JH
Arterioscler Thromb Vasc Biol; 2009 Apr; 29(4):539-47. PubMed ID: 19164809
[TBL] [Abstract][Full Text] [Related]
29. Accumulation of biglycan and perlecan, but not versican, in lesions of murine models of atherosclerosis.
Kunjathoor VV; Chiu DS; O'Brien KD; LeBoeuf RC
Arterioscler Thromb Vasc Biol; 2002 Mar; 22(3):462-8. PubMed ID: 11884291
[TBL] [Abstract][Full Text] [Related]
30. Ceramide in lipid particles enhances heparan sulfate proteoglycan and low density lipoprotein receptor-related protein-mediated uptake by macrophages.
Morita SY; Kawabe M; Sakurai A; Okuhira K; Vertut-Doï A; Nakano M; Handa T
J Biol Chem; 2004 Jun; 279(23):24355-61. PubMed ID: 15044445
[TBL] [Abstract][Full Text] [Related]
31. Grb2 is required for atherosclerotic lesion formation.
Proctor BM; Ren J; Chen Z; Schneider JG; Coleman T; Lupu TS; Semenkovich CF; Muslin AJ
Arterioscler Thromb Vasc Biol; 2007 Jun; 27(6):1361-7. PubMed ID: 17363695
[TBL] [Abstract][Full Text] [Related]
32. Protective role for Toll-like receptor-9 in the development of atherosclerosis in apolipoprotein E-deficient mice.
Koulis C; Chen YC; Hausding C; Ahrens I; Kyaw TS; Tay C; Allen T; Jandeleit-Dahm K; Sweet MJ; Akira S; Bobik A; Peter K; Agrotis A
Arterioscler Thromb Vasc Biol; 2014 Mar; 34(3):516-25. PubMed ID: 24436372
[TBL] [Abstract][Full Text] [Related]
33. Cysteamine inhibits lysosomal oxidation of low density lipoprotein in human macrophages and reduces atherosclerosis in mice.
Wen Y; Ahmad F; Mohri Z; Weinberg PD; Leake DS
Atherosclerosis; 2019 Dec; 291():9-18. PubMed ID: 31629988
[TBL] [Abstract][Full Text] [Related]
34. microRNA-185 modulates low density lipoprotein receptor expression as a key posttranscriptional regulator.
Jiang H; Zhang J; Du Y; Jia X; Yang F; Si S; Wang L; Hong B
Atherosclerosis; 2015 Dec; 243(2):523-32. PubMed ID: 26523989
[TBL] [Abstract][Full Text] [Related]
35. Impaired development of atherosclerosis in hyperlipidemic Ldlr-/- and ApoE-/- mice transplanted with Abcg1-/- bone marrow.
Baldán A; Pei L; Lee R; Tarr P; Tangirala RK; Weinstein MM; Frank J; Li AC; Tontonoz P; Edwards PA
Arterioscler Thromb Vasc Biol; 2006 Oct; 26(10):2301-7. PubMed ID: 16888235
[TBL] [Abstract][Full Text] [Related]
36. nSMase2 (Type 2-Neutral Sphingomyelinase) Deficiency or Inhibition by GW4869 Reduces Inflammation and Atherosclerosis in Apoe
Lallemand T; Rouahi M; Swiader A; Grazide MH; Geoffre N; Alayrac P; Recazens E; Coste A; Salvayre R; Nègre-Salvayre A; Augé N
Arterioscler Thromb Vasc Biol; 2018 Jul; 38(7):1479-1492. PubMed ID: 29794115
[TBL] [Abstract][Full Text] [Related]
37. The very low- and intermediate-density lipoprotein fraction isolated from apolipoprotein E-knockout mice transforms macrophages to foam cells through an apolipoprotein E-independent pathway.
Hakamata H; Sakaguchi H; Zhang C; Sakashita N; Suzuki H; Miyazaki A; Takeya M; Takahashi K; Kitamura N; Horiuchi S
Biochemistry; 1998 Sep; 37(39):13720-7. PubMed ID: 9753460
[TBL] [Abstract][Full Text] [Related]
38. Reduction of isoprostanes and regression of advanced atherosclerosis by apolipoprotein E.
Tangirala RK; Praticó D; FitzGerald GA; Chun S; Tsukamoto K; Maugeais C; Usher DC; Puré E; Rader DJ
J Biol Chem; 2001 Jan; 276(1):261-6. PubMed ID: 11024044
[TBL] [Abstract][Full Text] [Related]
39. Effect of an oral astaxanthin prodrug (CDX-085) on lipoprotein levels and progression of atherosclerosis in LDLR(-/-) and ApoE(-/-) mice.
Ryu SK; King TJ; Fujioka K; Pattison J; Pashkow FJ; Tsimikas S
Atherosclerosis; 2012 May; 222(1):99-105. PubMed ID: 22406426
[TBL] [Abstract][Full Text] [Related]
40. Serum Amyloid A Facilitates Early Lesion Development in Ldlr-/- Mice.
Krishack PA; Bhanvadia CV; Lukens J; Sontag TJ; De Beer MC; Getz GS; Reardon CA
J Am Heart Assoc; 2015 Jul; 4(7):. PubMed ID: 26187995
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
